| Variables | Observation level | ORb (95% CI) | p-value | ORa (95% CI) | p-value | ||
| Watching | Non-observant | ||||||
| Age range | <5 years | 68 | 216 | 1 |
|
|
|
| ≥5 years | 30 | 54 | 0.56 (0.33 - 0.95) | 0.032 | 0.96 (0.46 - 1.97) | 0.91 | |
| Residence | Niamey | 87 | 205 | 1 |
|
|
|
| Other regions | 11 | 65 | 2.50 (1.26 - 4.98) | 0.007 | 1.81 (0.66 - 4.98) | 0.24 | |
| Sex | M | 44 | 136 | 1 |
|
|
|
| F | 54 | 134 | 0.80 (0.50 - 1.27) | 0.35 |
|
| |
| Monthly income | >100,000 | 59 | 165 | 1 |
|
|
|
| ≥100,000 | 39 | 105 | 0.9725 (0.6 - 1.54) | 0.87 |
|
| |
| Health Insurance | Yes | 13 | 69 | 1 |
|
|
|
| No | 85 | 201 | 0.44 (0.23 - 0.84) | 0.012 | 0.36 (0.16 - 0.84) | 0.01 | |
| Diet | Monogamy | 53 | 136 | 1 |
|
|
|
| Polygamy | 77 | 231 | 1.54 (0.8 - 2.67) | 0.12 | 1.45 (0.74 - 2.82) | 0.27 | |
| Schooling | Yes | 36 | 202 | 1 |
|
|
|
| No | 98 | 270 | 0.19 (0.11 - 0.32) | <0.001 | 0.17 (0.10 - 0.30) | 0.0001 | |
| Knowledge of the disease | Yes | 95 | 233 | 1 |
|
|
|
| No | 3 | 37 | 5.02 (1.51 - 16.70) | 0.0037 | 7.68 (2.20 - 26.72) | 0.0014 | |
| Distance from center | <10 km | 33 | 153 | 1 |
|
|
|
| ≥10 km | 65 | 117 | 0.38 (0.23 - 0.62) | <0.0001 | 0.58 (0.33 - 0.99 | 0.04 | |
| Number of children with sickle cell disease in the family | ≤ 2 | 7 | 39 | 1 |
|
|
|
| >2 | 91 | 231 | 0.45 (0.19 - 1.05) | 0.06 | 0.98 (0.35 - 2.76) | 0.98 | |
| Occupation |
|
|
|
| 0.007 |
|
|
| Without |
|
| 1 |
|
|
| |
| Private sector |
|
| 1.93 (0.96 - 3.87) |
|
|
| |
| Public sector |
|
| 0.82 (0.36 - 1.86) |
|
|
| |
| Educational level |
|
|
|
| <0.001 |
|
|
| No level |
|
| 1 |
|
|
| |
| Primary |
|
| 0.10 (0.03 - 0.30) |
|
|
| |
| Primary |
|
| 0.30 (0.17 - 0.55) |
|
|
| |
| Superior |
|
| 0.13 (0.06 - 0.29) |
|
|
| |
| Number of hospitalizations/year | ≤3 | 9 | 23 | 1 |
|
|
|
| >3 | 89 | 247 | 1.08 (0.48 - 2.43) | 0.84 |
|
| |
| Number of crises per year | ≤5 | 21 | 86 | 1 |
|
|
|
| >5 | 77 | 184 | 0.58 (0.33 - 1.00) | 0.05 | 0.70 (0.32 - 1.53) | 0.38 | |
| Number of drugs per day | ≤ 2 | 55 | 142 | 1 |
|
|
|
| >2 | 43 | 128 | 1.15 (0.72 - 1.83) | 0.0014 | 1.91 (0.90 - 4.06) | 0.09 | |
| Use of personal vehicle | Yes | 18 | 117 | 1 |
|
|
|
| No | 80 | 153 | 0.74 (0.41 - 1.31) | 0.30 |
|
| |
| Stopping treatment | Yes | 18 | 117 | 1 |
|
|
|
| Boop | 80 | 153 | 0.29 (0.16 - 0.51) | 0.0001 | 0.15 (0.05 - 0.43) | 0.0004 | |
| Form of sickle cell disease | SS | 91 | 7 | 1 |
|
|
|
| CS | 248 | 22 | 1.15 (0.47 - 2.79) | 0.75 |
|
| |
| Number of analyzes requested per year | <5 | 12 | 80 | 1 |
|
|
|
| ≥5 | 86 | 190 | 0.33 (0.17 - 0.63) | 0.0006 | 1.06 (0.42 - 2.70) | 0.88 | |
| Duration of sickle cell status | <5 years | 46 | 52 | 1 |
|
|
|
| ≥5 years | 181 | 89 | 0.43 (0.27 - 0.69) | <0.001 | 0.51 (024 - 1.10) | 0.088 | |